
2023-2029 Global Allele Industry Research & Trends Analysis Report
Discover the latest insights into the booming Allele Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the latest research analysis,the global market for Allele should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Allele market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Allele market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Dominant segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Solving Crimes has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Allele include Allele Biotechnology, Generi Biotech, Spark Therapeutics, Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, SQZ Biotechnologies, Novartis Gene Therapies, Asklepios BioPharmaceutical, Inc. and Cellectis, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
A variation of the same sequence of nucleotides at the same place on a long DNA molecule, as described in leading textbooks on genetics and evolution.
This report aims to provide a comprehensive study of the global market for Allele.
Data-Driven Insights: Highlights from Our Report
(1) Global Allele market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Allele market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Allele market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Allele segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Allele segment by type and by application and regional segment by type and by application.
(6) Allele industry supply chain, upstream, midstream and downstream analysis.
Breaking Down Market Segments by Region: A Deep Dive Analysis
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Understanding Market Segments by Type: A Comparative Analysis
Dominant
Recessive
Market Segmentation by Application: Dividing Key Markets and Identifying Opportunities
Solving Crimes
Determining Paternity
Exploring one's Ancestry
Others
Understanding Market Segments by Key Players: Insights and Opportunities
Allele Biotechnology
Generi Biotech
Spark Therapeutics
Alnylam Pharmaceuticals
Arrowhead Pharmaceuticals
SQZ Biotechnologies
Novartis Gene Therapies
Asklepios BioPharmaceutical, Inc.
Cellectis
Pluristem Therapeutics Inc.
1 Market Overview
1.1 Product Overview and Scope of Allele
1.2 Global Allele Market Size and Forecast
1.3 China Allele Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Allele Share in Global Market, 2018-2029
1.4.2 Allele Market Size: China VS Global, 2018-2029
1.5 Allele Market Dynamics
1.5.1 Allele Market Drivers
1.5.2 Allele Market Restraints
1.5.3 Allele Industry Trends
1.5.4 Allele Industry Policy
2 Global Competitive Situation by Company
2.1 Global Allele Revenue by Company (2018-2023)
2.2 Global Allele Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Allele Concentration Ratio
2.4 Global Allele Mergers & Acquisitions, Expansion Plans
2.5 Global Allele Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Allele Revenue by Company (2018-2023)
3.2 China Allele Allele Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Allele, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Allele Industry Chain
4.2 Allele Upstream Analysis
4.3 Allele Midstream Analysis
4.4 Allele Downstream Analysis
5 Sights by Type
5.1 Allele Classification
5.1.1 Dominant
5.1.2 Recessive
5.2 By Type, Global Allele Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Allele Revenue, 2018-2029
6 Sights by Application
6.1 Allele Segment by Application
6.1.1 Solving Crimes
6.1.2 Determining Paternity
6.1.3 Exploring one's Ancestry
6.1.4 Others
6.2 By Application, Global Allele Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Allele Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Allele Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Allele Market Size, 2018-2029
7.3 North America
7.3.1 North America Allele Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Allele Market Size Market Share
7.4 Europe
7.4.1 Europe Allele Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Allele Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Allele Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Allele Market Size Market Share
7.6 South America
7.6.1 South America Allele Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Allele Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Allele Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Allele Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Allele Market Size, 2018-2029
8.3.2 By Company, U.S. Allele Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Allele Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Allele Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Allele Market Size, 2018-2029
8.4.2 By Company, Europe Allele Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Allele Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Allele Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Allele Market Size, 2018-2029
8.5.2 By Company, China Allele Revenue Market Share, 2018-2023
8.5.3 By Type, China Allele Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Allele Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Allele Market Size, 2018-2029
8.6.2 By Company, Japan Allele Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Allele Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Allele Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Allele Market Size, 2018-2029
8.7.2 By Company, South Korea Allele Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Allele Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Allele Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Allele Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Allele Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Allele Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Allele Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Allele Market Size, 2018-2029
8.9.2 By Company, India Allele Revenue Market Share, 2018-2023
8.9.3 By Type, India Allele Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Allele Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Allele Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Allele Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Allele Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Allele Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Allele Biotechnology
9.1.1 Allele Biotechnology Company Information, Head Office, Market Area and Industry Position
9.1.2 Allele Biotechnology Company Profile and Main Business
9.1.3 Allele Biotechnology Allele Models, Specifications and Application
9.1.4 Allele Biotechnology Allele Revenue and Gross Margin, 2018-2023
9.1.5 Allele Biotechnology Recent Developments
9.2 Generi Biotech
9.2.1 Generi Biotech Company Information, Head Office, Market Area and Industry Position
9.2.2 Generi Biotech Company Profile and Main Business
9.2.3 Generi Biotech Allele Models, Specifications and Application
9.2.4 Generi Biotech Allele Revenue and Gross Margin, 2018-2023
9.2.5 Generi Biotech Recent Developments
9.3 Spark Therapeutics
9.3.1 Spark Therapeutics Company Information, Head Office, Market Area and Industry Position
9.3.2 Spark Therapeutics Company Profile and Main Business
9.3.3 Spark Therapeutics Allele Models, Specifications and Application
9.3.4 Spark Therapeutics Allele Revenue and Gross Margin, 2018-2023
9.3.5 Spark Therapeutics Recent Developments
9.4 Alnylam Pharmaceuticals
9.4.1 Alnylam Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.4.2 Alnylam Pharmaceuticals Company Profile and Main Business
9.4.3 Alnylam Pharmaceuticals Allele Models, Specifications and Application
9.4.4 Alnylam Pharmaceuticals Allele Revenue and Gross Margin, 2018-2023
9.4.5 Alnylam Pharmaceuticals Recent Developments
9.5 Arrowhead Pharmaceuticals
9.5.1 Arrowhead Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.5.2 Arrowhead Pharmaceuticals Company Profile and Main Business
9.5.3 Arrowhead Pharmaceuticals Allele Models, Specifications and Application
9.5.4 Arrowhead Pharmaceuticals Allele Revenue and Gross Margin, 2018-2023
9.5.5 Arrowhead Pharmaceuticals Recent Developments
9.6 SQZ Biotechnologies
9.6.1 SQZ Biotechnologies Company Information, Head Office, Market Area and Industry Position
9.6.2 SQZ Biotechnologies Company Profile and Main Business
9.6.3 SQZ Biotechnologies Allele Models, Specifications and Application
9.6.4 SQZ Biotechnologies Allele Revenue and Gross Margin, 2018-2023
9.6.5 SQZ Biotechnologies Recent Developments
9.7 Novartis Gene Therapies
9.7.1 Novartis Gene Therapies Company Information, Head Office, Market Area and Industry Position
9.7.2 Novartis Gene Therapies Company Profile and Main Business
9.7.3 Novartis Gene Therapies Allele Models, Specifications and Application
9.7.4 Novartis Gene Therapies Allele Revenue and Gross Margin, 2018-2023
9.7.5 Novartis Gene Therapies Recent Developments
9.8 Asklepios BioPharmaceutical, Inc.
9.8.1 Asklepios BioPharmaceutical, Inc. Company Information, Head Office, Market Area and Industry Position
9.8.2 Asklepios BioPharmaceutical, Inc. Company Profile and Main Business
9.8.3 Asklepios BioPharmaceutical, Inc. Allele Models, Specifications and Application
9.8.4 Asklepios BioPharmaceutical, Inc. Allele Revenue and Gross Margin, 2018-2023
9.8.5 Asklepios BioPharmaceutical, Inc. Recent Developments
9.9 Cellectis
9.9.1 Cellectis Company Information, Head Office, Market Area and Industry Position
9.9.2 Cellectis Company Profile and Main Business
9.9.3 Cellectis Allele Models, Specifications and Application
9.9.4 Cellectis Allele Revenue and Gross Margin, 2018-2023
9.9.5 Cellectis Recent Developments
9.10 Pluristem Therapeutics Inc.
9.10.1 Pluristem Therapeutics Inc. Company Information, Head Office, Market Area and Industry Position
9.10.2 Pluristem Therapeutics Inc. Company Profile and Main Business
9.10.3 Pluristem Therapeutics Inc. Allele Models, Specifications and Application
9.10.4 Pluristem Therapeutics Inc. Allele Revenue and Gross Margin, 2018-2023
9.10.5 Pluristem Therapeutics Inc. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Research Methodology:
Allele Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|